Mechanism of YLTZ on glycolipid metabolism based on UPLC/TOF/MS metabolomics

Type 2 diabetes mellitus (T2DM) is a metabolic disease characterized by dysfunction of glycolipid metabolism. YLTZ is used to treat hyperlipidemia, yet its hypolipidemic and hypoglycemic mechanism on T2DM are unknown. Thus, UPLC/TOF/MS was applied in this study to identify the potential bio-markers,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2018-10, Vol.1097-1098, p.128-141
Hauptverfasser: Zhuo, Jun-cheng, Cai, Da-ke, Xie, Kai-feng, Gan, Hai-ning, Li, Sha-sha, Huang, Xue-jun, Huang, Dane, Zhang, Cheng-zhe, Li, Ru-yue, Chen, Yu-xing, Zeng, Xiao-hui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!